Addressing Hypertriglyceridemia and Cardiovascular Risk in Diabetes
There is growing evidence that the addition of triglyceride-lowering medication and lifestyle changes may be valuable in diabetes management.
All articles by Endocrinology Advisor Contributing Writer
IL-1 Inhibition as Targeted Treatment for Rheumatoid Arthritis, Type 2 Diabetes
Researchers investigated the role of interleukin-1 inhibition in improving glycemic and inflammatory parameters in patients with rheumatoid arthritis and type 2 diabetes.
Elevated Triglycerides Linked to Worse CV and Health Economic Outcomes
Researchers used using observational administrative claims data from the Optum Research Database to retrospectively examine the real-world effect of elevated triglyceride levels on cardiovascular outcomes and medical cost.
Burnout and Work-Life Integration: Physicians vs Other US Workers
Although rates of burnout and satisfaction with work-life integration improved among US physicians between 2014 and 2017, they still face an increased risk for burnout compared with workers in other fields.
Majority of Physicians Believe ACA Has Had Positive Effect on Health Care
The percentage of US physicians who believe that the ACA is a net positive for health care has increased in the five years after its implementation.
Genetically Increased Serum Calcium Not Linked to Improved BMD, Reduced Fracture Risk
Researchers assessed the effect of genetically predicted higher serum calcium levels on bone mineral density and the risk for fracture, using Mendelian randomization.
High LDL-C Not Causally Linked to Risk for Retinopathy and Neuropathy
Investigators analyzed whether high LDL-C causally relates to risk for retinopathy, neuropathy, chronic kidney disease, and peripheral artery disease in the general population.
Pharmacodynamics of Adjunctive Vorapaxar With DAPT in Type 2 Diabetes
Investigators examined the effects of vorapaxar on thrombotic cardiovascular events in patients with atherosclerotic disease and type 2 diabetes.
No Improvement in Bone Mineral Density With TNFi Therapy in RA With Osteoporosis
A retrospective study was performed to investigate the effects of TNFi on bone mineral density in patients with RA who received bisphosphonate.
Evolocumab Rapidly Reduces LDL-C When Added to High-Intensity Statin in ACS
Researchers evaluated how feasible, safe, and effective evolocumab is at lowering low-density lipoprotein cholesterol when initiated in patients hospitalized with acute coronary syndrome.
Next post in Cardiovascular and Metabolic Disorders
